Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Prüss H[au]:

A clinical approach to diagnosis of autoimmune encephalitis. Graus F et al. Lancet Neurol. (2016)

Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment. Steiner J et al. World J Biol Psychiatry. (2018)

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Mueller SH et al. Ann Neurol. (2018)

Search results

Items: 1 to 50 of 158

1.

Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.

Endres D, Leypoldt F, Bechter K, Hasan A, Steiner J, Domschke K, Wandinger KP, Falkai P, Arolt V, Stich O, Rauer S, Prüss H, van Elst LT.

Eur Arch Psychiatry Clin Neurosci. 2020 Mar 12. doi: 10.1007/s00406-020-01113-2. [Epub ahead of print] Review.

PMID:
32166503
2.

Probable Autoimmune Catatonia With Antibodies Against Cilia on Hippocampal Granule Cells and Highly Suspicious Cerebral FDG-Positron Emission Tomography Findings.

Endres D, Prüss H, Rauer S, Süß P, Venhoff N, Feige B, Schweizer T, Nickel K, Maier S, Egger K, Domschke K, Meyer PT, Tebartz van Elst L.

Biol Psychiatry. 2020 Feb 28. pii: S0006-3223(19)31982-1. doi: 10.1016/j.biopsych.2019.12.020. [Epub ahead of print] No abstract available.

PMID:
32122620
3.

Autoimmune psychosis - Authors' reply.

Pollak TA, Prüss H, van Elst LT, Vincent A, Najjar S, Bechter K.

Lancet Psychiatry. 2020 Feb;7(2):123-125. doi: 10.1016/S2215-0366(19)30527-9. No abstract available.

PMID:
31981531
4.

Response by Sperber et al to Letter Regarding Article, "Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B)".

Sperber PS, Prüss H, Siegerink B, Liman TG.

Stroke. 2020 Feb;51(2):e29. doi: 10.1161/STROKEAHA.119.028095. Epub 2020 Jan 13. No abstract available.

PMID:
31928150
5.

Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability.

Kornau HC, Kreye J, Stumpf A, Fukata Y, Parthier D, Sammons RP, Imbrosci B, Kurpjuweit S, Kowski AB, Fukata M, Prüss H, Schmitz D.

Ann Neurol. 2020 Mar;87(3):405-418. doi: 10.1002/ana.25666. Epub 2020 Jan 27.

PMID:
31900946
6.

Reply to "Pregnancy, N-Methyl-D-Aspartate Receptor Antibodies, and Neuropsychiatric Diseases".

Jurek B, Chayka M, Kreye J, Koelch M, Prüss H.

Ann Neurol. 2020 Feb;87(2):325-326. doi: 10.1002/ana.25653. Epub 2019 Dec 10. No abstract available.

PMID:
31782158
7.

Psychiatric Presentation of Anti-NMDA Receptor Encephalitis.

Endres D, Rauer S, Kern W, Venhoff N, Maier SJ, Runge K, Süß P, Feige B, Nickel K, Heidt T, Domschke K, Egger K, Prüss H, Meyer PT, Tebartz van Elst L.

Front Neurol. 2019 Nov 5;10:1086. doi: 10.3389/fneur.2019.01086. eCollection 2019.

8.

Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin.

Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K.

Lancet Psychiatry. 2020 Jan;7(1):93-108. doi: 10.1016/S2215-0366(19)30290-1. Epub 2019 Oct 24. Review. Erratum in: Lancet Psychiatry. 2019 Dec;6(12):e31.

PMID:
31669058
9.

Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.

Scheibe F, Ostendorf L, Reincke SM, Prüss H, von Brünneck AC, Köhnlein M, Alexander T, Meisel C, Meisel A.

J Neurol. 2020 Feb;267(2):317-323. doi: 10.1007/s00415-019-09585-6. Epub 2019 Oct 19.

PMID:
31630242
10.

Normal gut microbiome in NMDA receptor encephalitis.

Herken J, Bang C, Rühlemann MC, Finke C, Klag J, Franke A, Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 17;6(6). pii: e632. doi: 10.1212/NXI.0000000000000632. Print 2019 Nov.

12.

Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).

Sperber PS, Siegerink B, Huo S, Rohmann JL, Piper SK, Prüss H, Heuschmann PU, Endres M, Liman TG.

Stroke. 2019 Nov;50(11):3213-3219. doi: 10.1161/STROKEAHA.119.026100. Epub 2019 Sep 17. Erratum in: Stroke. 2019 Nov;50(11):e343.

PMID:
31526121
13.

IgA autoantibodies against native myelin basic protein in a patient with MS.

Schumacher H, Wenke NK, Kreye J, Höltje M, Marcus K, May C, Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2019 May 1;6(4):e569. doi: 10.1212/NXI.0000000000000569. eCollection 2019 Jul. No abstract available.

14.

Human gestational N-methyl-d-aspartate receptor autoantibodies impair neonatal murine brain function.

Jurek B, Chayka M, Kreye J, Lang K, Kraus L, Fidzinski P, Kornau HC, Dao LM, Wenke NK, Long M, Rivalan M, Winter Y, Leubner J, Herken J, Mayer S, Mueller S, Boehm-Sturm P, Dirnagl U, Schmitz D, Kölch M, Prüss H.

Ann Neurol. 2019 Nov;86(5):656-670. doi: 10.1002/ana.25552. Epub 2019 Sep 18.

PMID:
31325344
15.

Linkage Evidence for a Two-Locus Inheritance of LQT-Associated Seizures in a Multigenerational LQT Family With a Novel KCNQ1 Loss-of-Function Mutation.

Prüss H, Gessner G, Heinemann SH, Rüschendorf F, Ruppert AK, Schulz H, Sander T, Rimpau W.

Front Neurol. 2019 Jun 25;10:648. doi: 10.3389/fneur.2019.00648. eCollection 2019.

16.

[Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment].

Tebartz van Elst L, Bechter K, Prüss H, Hasan A, Steiner JH, Leypoldt F, Endres D.

Nervenarzt. 2019 Jul;90(7):745-761. doi: 10.1007/s00115-019-0735-1. German.

PMID:
31197396
17.

Olfactory and Gustatory Dysfunction in Patients With Autoimmune Encephalitis.

Geran R, Uecker FC, Prüss H, Haeusler KG, Paul F, Ruprecht K, Harms L, Schmidt FA.

Front Neurol. 2019 May 14;10:480. doi: 10.3389/fneur.2019.00480. eCollection 2019.

18.

N-methyl-d-aspartate receptor encephalitis with a reversible splenial lesion.

Kaminski JA, Prüss H.

Eur J Neurol. 2019 Jun;26(6):e68-e69. doi: 10.1111/ene.13900. No abstract available.

PMID:
31034742
19.

[Autoantibody-associated schizophreniform psychoses: clinical symptomatology].

Endres D, Bechter K, Prüss H, Hasan A, Steiner J, Leypoldt F, Tebartz van Elst L.

Nervenarzt. 2019 May;90(5):547-563. doi: 10.1007/s00115-019-0700-z. German.

PMID:
30968197
20.

Atypical Autoimmune Encephalitis With Neuropil Antibodies Against a Yet Unknown Epitope.

Edwin Thanarajah S, Prüss H, Warnke C, Barbe MT, Schroeter M, Fink GR, Onur OA.

Front Neurol. 2019 Mar 5;10:175. doi: 10.3389/fneur.2019.00175. eCollection 2019.

21.

GABAB receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis.

Schumacher H, Meyer T, Prüss H.

BMC Neurol. 2019 Mar 14;19(1):41. doi: 10.1186/s12883-019-1269-7.

22.

N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit.

Wenke NK, Kreye J, Andrzejak E, van Casteren A, Leubner J, Murgueitio MS, Reincke SM, Secker C, Schmidl L, Geis C, Ackermann F, Nikolaus M, Garner CC, Wardemann H, Wolber G, Prüss H.

Ann Neurol. 2019 May;85(5):771-776. doi: 10.1002/ana.25460. Epub 2019 Apr 2.

23.

Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment.

Schubert J, Brämer D, Huttner HB, Gerner ST, Fuhrer H, Melzer N, Dik A, Prüss H, Ly LT, Fuchs K, Leypoldt F, Nissen G, Schirotzek I, Dohmen C, Bösel J, Lewerenz J, Thaler F, Kraft A, Juranek A, Ringelstein M, Sühs KW, Urbanek C, Scherag A, Geis C, Witte OW, Günther A; GENERATE and IGNITE network.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 30;6(1):e514. doi: 10.1212/NXI.0000000000000514. eCollection 2019 Jan.

24.

Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment.

Steiner J, Prüss H, Köhler S, Frodl T, Hasan A, Falkai P.

World J Biol Psychiatry. 2018 Dec 4:1-14. doi: 10.1080/15622975.2018.1555376. [Epub ahead of print]

PMID:
30513253
25.

Admission diagnoses of patients later diagnosed with autoimmune encephalitis.

Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O.

J Neurol. 2019 Jan;266(1):124-132. doi: 10.1007/s00415-018-9105-3. Epub 2018 Nov 12.

PMID:
30421340
26.

CSF reactivity in GABAA receptor antibody encephalitis - Immunocytochemical distribution in the murine brain.

Nikolaus M, Kreye J, Turko P, Vida I, Knierim E, Prüss H.

Brain Res. 2019 Feb 1;1704:249-256. doi: 10.1016/j.brainres.2018.10.019. Epub 2018 Oct 19. Review.

PMID:
30347219
27.

A cross-species approach to disorders affecting brain and behaviour.

Devinsky O, Boesch JM, Cerda-Gonzalez S, Coffey B, Davis K, Friedman D, Hainline B, Houpt K, Lieberman D, Perry P, Prüss H, Samuels MA, Small GW, Volk H, Summerfield A, Vite C, Wisniewski T, Natterson-Horowitz B.

Nat Rev Neurol. 2018 Nov;14(11):677-686. doi: 10.1038/s41582-018-0074-z. Review.

28.

Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis.

Körtvelyessy P, Prüss H, Thurner L, Maetzler W, Vittore-Welliong D, Schultze-Amberger J, Heinze HJ, Reinhold D, Leypoldt F, Schreiber S, Bittner D.

Front Neurol. 2018 Sep 19;9:668. doi: 10.3389/fneur.2018.00668. eCollection 2018.

29.

Pathogenic role of autoantibodies against inhibitory synapses.

Prüss H, Kirmse K.

Brain Res. 2018 Dec 15;1701:146-152. doi: 10.1016/j.brainres.2018.09.009. Epub 2018 Sep 8. Review.

PMID:
30205110
30.

Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics.

Ly LT, Kreye J, Jurek B, Leubner J, Scheibe F, Lemcke J, Wenke NK, Reincke SM, Prüss H.

J Neurol. 2018 Nov;265(11):2625-2632. doi: 10.1007/s00415-018-9042-1. Epub 2018 Sep 5.

31.

Further reducing terra incognita on the map of synaptic autoimmunity.

Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 2;5(5):e489. doi: 10.1212/NXI.0000000000000489. eCollection 2018 Sep. No abstract available.

32.

Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.

Bartels F, Prüss H, Finke C.

Front Neurol. 2018 Aug 10;9:656. doi: 10.3389/fneur.2018.00656. eCollection 2018.

33.

Correction: Functional autoantibodies in patients with different forms of dementia.

Wallukat G, Prüss H, Müller J, Schimke I.

PLoS One. 2018 Aug 27;13(8):e0203253. doi: 10.1371/journal.pone.0203253. eCollection 2018.

34.

Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study.

Thyrian JR, Hertel J, Schulze LN, Dörr M, Prüss H, Hempel P, Bimmler M, Kunze R, Grabe HJ, Teipel S, Hoffmann W.

J Alzheimers Dis. 2018;64(4):1091-1097. doi: 10.3233/JAD-171096.

PMID:
30010118
35.

Capital jurors, mental illness, and the unreliability principle: Can capital jurors comprehend and account for evidence of mental illness?

Sandys M, Pruss H, Walsh SM.

Behav Sci Law. 2018 Jul 13. doi: 10.1002/bsl.2355. [Epub ahead of print]

PMID:
30004140
36.

Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis.

Heine J, Prüss H, Kopp UA, Wegner F, Then Bergh F, Münte T, Wandinger KP, Paul F, Bartsch T, Finke C.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1191-1199. doi: 10.1136/jnnp-2017-317780. Epub 2018 Jun 9.

PMID:
29886429
37.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

38.

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE).

Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216.

PMID:
29572931
39.

Functional autoantibodies in patients with different forms of dementia.

Wallukat G, Prüss H, Müller J, Schimke I.

PLoS One. 2018 Mar 14;13(3):e0192778. doi: 10.1371/journal.pone.0192778. eCollection 2018. Erratum in: PLoS One. 2018 Aug 27;13(8):e0203253.

40.

[Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach].

Steiner J, Prüß H, Köhler S, Hasan A, Falkai P.

Nervenarzt. 2018 May;89(5):530-538. doi: 10.1007/s00115-018-0499-z. Review. German.

PMID:
29523913
41.

Severe GABAA receptor encephalitis without seizures: A paediatric case successfully treated with early immunomodulation.

Nikolaus M, Knierim E, Meisel C, Kreye J, Prüss H, Schnabel D, Kallinich T.

Eur J Paediatr Neurol. 2018 May;22(3):558-562. doi: 10.1016/j.ejpn.2018.01.002. Epub 2018 Jan 9.

PMID:
29396172
42.

High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders.

Lütt A, Michel K, Krüger D, Volz MS, Nassir M, Schulz E, Poralla L, Tangermann P, Bojarski C, Höltje M, Teegen B, Stöcker W, Schemann M, Siegmund B, Prüss H.

Neurogastroenterol Motil. 2018 Jun;30(6):e13292. doi: 10.1111/nmo.13292. Epub 2018 Jan 18.

PMID:
29345029
43.

Pursuing functional connectivity in NMDAR1 autoantibody carriers - Authors' reply.

Peer M, Prüss H, Ben-Dayan I, Paul F, Arzy S, Finke C.

Lancet Psychiatry. 2018 Jan;5(1):22. doi: 10.1016/S2215-0366(17)30488-1. No abstract available.

PMID:
29277209
44.

Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child.

Nikolaus M, Jackowski-Dohrmann S, Prüss H, Schuelke M, Knierim E.

Neurology. 2018 Jan 23;90(4):183-185. doi: 10.1212/WNL.0000000000004861. Epub 2017 Dec 20. No abstract available.

PMID:
29263225
45.

A case of CLIPPERS challenging the new diagnostic criteria.

Rössling R, Pehl D, Lingnau M, Prüss H.

Brain. 2018 Feb 1;141(2):e12. doi: 10.1093/brain/awx335. No abstract available.

PMID:
29253092
46.

Superficial white matter damage in anti-NMDA receptor encephalitis.

Phillips OR, Joshi SH, Narr KL, Shattuck DW, Singh M, Di Paola M, Ploner CJ, Prüss H, Paul F, Finke C.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):518-525. doi: 10.1136/jnnp-2017-316822. Epub 2017 Nov 3.

47.

Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflex.

Prüss H, Tedeschi A, Thiriot A, Lynch L, Loughhead SM, Stutte S, Mazo IB, Kopp MA, Brommer B, Blex C, Geurtz LC, Liebscher T, Niedeggen A, Dirnagl U, Bradke F, Volz MS, DeVivo MJ, Chen Y, von Andrian UH, Schwab JM.

Nat Neurosci. 2017 Nov;20(11):1549-1559. doi: 10.1038/nn.4643. Epub 2017 Sep 18.

PMID:
28920935
48.

Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.

Peer M, Prüss H, Ben-Dayan I, Paul F, Arzy S, Finke C.

Lancet Psychiatry. 2017 Oct;4(10):768-774. doi: 10.1016/S2215-0366(17)30330-9. Epub 2017 Sep 4.

PMID:
28882707
49.

High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.

Finke C, Bartels F, Lütt A, Prüss H, Harms L.

J Neurol. 2017 Sep;264(9):1968-1977. doi: 10.1007/s00415-017-8582-0. Epub 2017 Aug 7.

PMID:
28785798
50.

Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity.

Lang K, Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e386. doi: 10.1212/NXI.0000000000000386. eCollection 2017 Sep. Review.

Supplemental Content

Support Center